$14.46
+0.56 (+4.03%)
Analyst Consensus
Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+107.9% upside
Low Target
$17.22
Average Target
$30.06
High Target
$35.82
Current Price
$14.46
Current
$14.46
$14.46
Target
$30.06
$30.06
$17.22
$30.06 avg
$35.82
Scenario Analysis
Bear Case
$17.22
19.1%
Low target
Base Case
$30.06
+107.9%
Avg target
Bull Case
$35.82
+147.7%
High target
Risk/Reward
7.7x
Highly favorable
Price in Context
52-Week High
$18.24
-20.7% from high
52-Week Low
$7.48
+93.3% from low
Target vs 52W High
$30.06
+64.8% vs high
Next Earnings Report
Nov 17, 2026
9d
until earnings
EPS Est: $-0.76
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |